イメージ埼玉県 越谷市七左町1-304-1
東武伊勢崎線・新越谷駅西口またはJR武蔵野線・南越谷駅より徒歩16分(無料送迎車あり)
Prostate cancer is the most frequently diagnosed cancer among Japanese men. While it tends to progress relatively slowly, it becomes difficult to treat once it has spread. PSA (prostate-specific antigen) testing is a blood test and is the only screening tool considered effective for early detection. If PSA levels are elevated, further workup with MRI or biopsy is recommended.
In nationwide, 1368 facilities offer tests related to the early detection of Prostate Cancer.
A blood test that checks for the possibility of prostate cancer (Prostate-Specific Antigen)
Recommended frequency
Men aged 50 and older (or 40 and older if there is a family history) are advised to have a PSA test once a year.
Links to the dedicated page for each area
イメージ埼玉県 越谷市七左町1-304-1
東武伊勢崎線・新越谷駅西口またはJR武蔵野線・南越谷駅より徒歩16分(無料送迎車あり)
イメージ
イメージ(医)社団アルコ会アルコクリニック の総合健診センター
東京都 目黒区下目黒1-8-1 アルコタワー12F
JR山手線・東急目黒線・東京メトロ南北線・都営三田線「目黒駅」西口より徒歩5分
イメージ東京都 新宿区新宿2-5-12-3F
東京メトロ丸ノ内線「新宿御苑前駅」1番出口より徒歩3分
イメージ東京都 品川区大崎2-1-1Thinkpark Tower3F
JR大崎駅直結のThinkPark Tower3階、徒歩2分
イメージ東京都 新宿区西新宿3-2-4
新宿駅南口より徒歩7分
イメージ東京都 港区港南2-16-3 品川グランドセントラルタワー1F
品川駅 港南口(東口)から徒歩4分、港区の健康管
イメージ神奈川県 横浜市西区みなとみらい2-2-1-1 ランドマークタワー7F
JR桜木町駅・みなとみらい線みなとみらい駅・市営地下鉄桜木町駅より徒歩5分、ランドマークプラザ1F
イメージ大阪府 大阪市天王寺区東高津町7-11 大阪府教育会館5階
近鉄大阪上本町駅(中央改札口)より徒歩約5分
イメージ
イメージ
イメージFor the early detection of Prostate Cancer, PSA (Prostate-Specific Antigen) are effective. Prostate cancer is the most frequently diagnosed cancer among Japanese men. While it tends to progress relatively slowly, it becomes difficult to treat once it has spread. PSA (prostate-specific antigen) testing is a blood test and is the only screening tool considered effective for early detection. If PSA levels are elevated, further workup with MRI or biopsy is recommended.
Men aged 50 and older (or 40 and older if there is a family history) are advised to have a PSA test once a year.
This site lists 1368 health checkup facilities that offer at least one of the tests related to Prostate Cancer (PSA (Prostate-Specific Antigen)).
The information on this page references the clinical guidelines of the academic societies below. Please see each link for details and the latest version.